Olink

Olink®
Part of Thermo Fisher Scientific

The Effect of Preanalytical Conditions on Blood-Based Inflammation Biomarkers

Journal of Proteome Research, 2025

O’Donnell T., Weinstein S., Yano Y., Albert P., Black A., Brotzman M., Diaz-Mayoral N., Shreves A., Gerlanc N., Wyatt K., Gaudet M., Abnet C., Wentzensen N.

Disease areaApplication areaSample typeProducts
Technical Studies
Technical Evaluation
Plasma
Serum
Olink Target 96

Olink Target 96

Abstract

Blood-based inflammation biomarkers have potential for diagnostic, prognostic, and predictive testing, but preanalytical processing conditions can affect biomarker levels. We investigated how needle-to-freezer time, centrifugation timing, and tube types influence inflammation biomarkers. Twenty subjects donated 21 different blood samples in collection tubes, including plasma and serum types. Ninety-two biomarkers from each sample were analyzed using the Olink Target 96 Inflammation panel. We compared biomarker concentrations across different preanalytical variables to a reference standard tube. Intraclass, Pearson, and Spearman’s correlation coefficients were calculated. We also assessed the impact of these conditions on age-related associations with biomarkers. Across the preprocessing protocol/blood matrix combinations, 38%–83%, 50%–87%, and 47%–79% of proteins showed good to excellent correlations in intraclass, Pearson, and Spearman analyses, respectively. Eighteen proteins differed by >0.5 NPX units between test and reference protocols. Among 30 comparisons of age-related biomarker associations showing p ≤ 0.05 at baseline, 12 (40%) maintained a p ≤ 0.05 across all needle-to-freezer times. Many proteins in the Olink Target 96 Inflammation panel exhibited robust stability across various preanalytical conditions, indicating that blood-based inflammation biomarkers are suitable for testing across different blood specimen types. Further studies are needed to evaluate the impact of long-term storage.

Read publication ↗